Viewing Study NCT00003561


Ignite Creation Date: 2025-12-24 @ 12:24 PM
Ignite Modification Date: 2026-01-27 @ 6:40 AM
Study NCT ID: NCT00003561
Status: TERMINATED
Last Update Posted: 2011-07-20
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic phase chronic myelogenous leukemia View
None Philadelphia chromosome positive chronic myelogenous leukemia View
None Philadelphia chromosome negative chronic myelogenous leukemia View